IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blinded Pilot Study

다국어 초록 (Multilingual Abstract)

Background/Aims: Immunoglobulin G4 (IgG4)-associated cholangiopathy (IAC) is an inflammatory disease and may mimic primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA), or pancreatic cancer on cholangiography. We investigated whether IgG4 levels in bile aspirated during endoscopic retrograde cholangiopancreatography (ERCP) can distinguish IAC from PSC, CCA, and pancreatic cancer. Methods: Bile was aspirated directly from the common bile duct during ERCP in patients with IAC prior to steroid therapy. For control purposes, bile was obtained from patients with PSC, CCA, pancreatic cancer, and benign biliary conditions (sphincter of oddi dysfunction/choledocholithiasis). Results: Biliary IgG4 levels were measured in 54 patients. The median bile IgG4 levels were markedly elevated in patients with IAC (5.5 mg/dL; interquartile range [IQR], 5.1 to 15.6) as compared to patients with benign biliary conditions (0 mg/dL; IQR, 0 to 0.1; p=0.003). The median biliary IgG4 levels in PSC, CCA, and pancreatic cancer were 1.2 (IQR, 0.2 to 3.8), 0.9 (IQR, 0.2 to 3.4), and 0.2 mg/dL (IQR, 0.1 to 0.8), respectively. A cutoff value of 3.8 mg/dL distinguished IAC from PSC and CCA patients with 100% and 76.9% sensitivity and specificity, respectively. Conclusions: The results of this pilot study suggest that measurement of biliary IgG4 levels may have clinical value in distinguishing patients with IAC from biliary disorders that can mimic IAC.

참고문헌 (Reference)

1 Oseini AM, "Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma" 54 : 940-948, 2011

2 Vosskuhl K, "Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy" 44 : 48-52, 2012

3 Hirano K, "Involvement of the biliary system in autoimmune pancreatitis: a follow-up study" 1 : 453-464, 2003

4 Erdogan D, "Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures" 95 : 727-734, 2008

5 Ghazale A, "Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy" 134 : 706-715, 2008

6 Björnsson E, "Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature" 45 : 1547-1554, 2007

7 Umemura T, "Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis" 46 : 463-471, 2007

8 Zen Y, "IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?" 28 : 1193-1203, 2004

9 Stone JH, "IgG4-related disease" 366 : 539-551, 2012

10 Zhang L, "IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis" 34 : 88-94, 2010

11 Moon SH, "IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis" 71 : 960-966, 2010

12 Kalaitzakis E, "Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma" 9 : 800-803, 2011

13 Mendes FD, "Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis" 101 : 2070-2075, 2006

14 Navaneethan U, "Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis" 7 : e35-e41, 2013

15 Kamisawa T, "Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease" 41 : 613-625, 2006

16 Kamisawa T, "A new diagnostic endoscopic tool for autoimmune pancreatitis" 68 : 358-361, 2008